BIOGRAPHICAL SKETCH
NAME: KEE HYUN NAM
POSITION TITLE: Professor, Director of thyroid cancer center, Yonsei University College of Medicine
INSTITUTION AND LOCATION DEGREE FIELD OF STUDY
Yonsei University College of Medicine, Seoul, Korea M.D. 02/ 1996 Medicine
The Graduate School, Yonsei, University, Seoul, Korea Master's 08 / 2004 Surgery
The Graduate School, Yonsei, University, Seoul, Korea Ph.D. 08 / 2010 Surgery
A. Personal Statement
I am a Professor and chief in division of endocrine surgery from Yonsei University Health System, and my research is focused on Single-port Transaxillary Robotic Thyroidectomy (START), minimally invasive thyroidectomy (MIT) using open technique and Tumor behavior of thyroid cancer using translational study. In addition, I am interested in developing new biomaterials to prevent postoperative adhesion in surgical field
B. Positions, Scientific Appointments, and Honors
2024 – Present Chief, Department of Surgery, Severance Hospital, Yonsei University
2023 – Present Chief of Endocrine Surgery, Severance Hospital, Yonsei University
2017 – 2024 Director, Thyroid cancer center, Yonsei Cancer Hospital, Yonsei University
2016 – Present Professor, Department of Surgery, Yonsei University College of Medicine
2011 – 2015 Associate Professor, Department of Surgery, Yonsei University College of Medicine
2010 - 2012 Visiting fellowship, Department of Surgery, Mount Sinai Medical Center, New York, USA
2006 – 2010 Assistant Professor, Department of Surgery, Yonsei University College of Medicine
2004 - 2006 Instructor in Department of Surgery, Yonsei University College of Medicine,
C. Contributions to Science
1. My publications related to robotic transaxillary thyroidectomy using SP or multiport system
Single-Port Transaxillary Robotic Modified Radical Neck Dissection (STAR-RND): Initial Experiences.
Ho J, Kim D, Lee JE, Kim JK, Lee CR, Kang SW, Jeong JJ, Nam KH, Chung WY. Laryngoscope. 2023
Mar;133(3):709-714. doi: 10.1002/lary.30437. Epub 2022 Oct 29
Single-port transaxillary robotic thyroidectomy (START): 200-cases with two-step retraction method.
Kim JK, Choi SH, Choi SM, Choi HR, Lee CR, Kang SW, Jeong JJ, Nam KH, Chung WY. Surg Endosc. 2021 Nov 5. doi: 10.1007/s00464-021-08837-9.
Robotic Transaxillary Hemithyroidectomy Using the da Vinci SP Robotic System: Initial Experience With 10 Consecutive Cases. Kim K, Kang SW, Kim JK, Lee CR, Lee J, Jeong JJ, Nam KH, Chung WY. Surg Innov. 2020 Jun;27(3):256-264. doi: 10.1177/1553350620909279. Epub 2020 Mar 4.
Surgical complications after robotic thyroidectomy for thyroid carcinoma: a single center experience with 3,000 patients. Ban EJ, Yoo JY, Kim WW, Son HY, Park S, Lee SH, Lee CR, Kang SW, Jeong JJ, Nam KH, Chung WY, Park CS.Surg Endosc. 2014 Sep;28(9):2555-63. doi: 10.1007/s00464-014-3502-1. Epub 2014 Mar 20.
Prevention of complications in transaxillary single-incision robotic thyroidectomy. Nam KH, Owen R, Inabnet WB 3rd. Thyroid. 2012 Dec;22(12):1266-74. doi: 10.1089/thy.2012.0068.
2. My publication related to minimally invasive thyroidectomy using open technique
Surgical outcomes of minimally invasive thyroidectomy in thyroid cancer: comparison with conventional open thyroidectomy. Kim K, Kang SW, Kim JK, Lee CR, Lee J, Jeong JJ, Nam KH, Chung WY. Gland Surg. 2020 Oct;9(5):1172-1181. doi: 10.21037/gs-20-512.
3. My publications related to the clinicopathological study of thyroid cancer
Clinical Utility of Preoperative Vitamin D3 Injection for Preventing Transient Hypocalcemia after Total Thyroidectomy. Kim K, Lee CR, Kang SW, Lee J, Jeong JJ, Nam KH, Chung WY.
Int J Endocrinol. 2021
Cystic Lateral Lymph Node Metastases From Papillary Thyroid Cancer Patients.
Kim JK, Kim MJ, Choi SH, Choi SM, Choi HR, Lee CR, Kang SW, Lee J, Jeong JJ, Nam KH, Chung WY.
Laryngoscope. 2020 Dec;130(12):E976-E981
Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
Choi JB, Lee SG, Kim MJ, Kim TH, Ban EJ, Lee CR, Lee J, Kang SW, Jeong JJ, Nam KH, Chung WY, Park CS.
Head Neck. 2019 Jan;41(1):56-63.
Is familial papillary thyroid microcarcinoma more aggressive than sporadic form?
Lee CR, Park S, Kang SW, Lee J, Jeong JJ, Nam KH, Chung WY, Park CS. Ann Surg Treat Res. 2017
Is Preoperative Vitamin D Deficiency a Risk Factor for Postoperative Symptomatic Hypocalcemia in Thyroid Cancer Patients Undergoing Total Thyroidectomy Plus Central Compartment Neck Dissection?
Kim WW, Chung SH, Ban EJ, Lee CR, Kang SW, Jeong JJ, Nam KH, Chung WY, Park CS.
Thyroid. 2015 Aug;25(8):911-8.
Relationship between onset of hypocalcemic symptoms and the recovery time from transient hypocalcemia after total thyroidectomy. Lee YS, Chang HS, Chung WY, Nam KH, Park CS. Head Neck. 2014 Dec;36(12):1732-6
4. My publications related to translational research for thyroid cancer
TERT Promoter and BRAF V600E Mutations in Papillary Thyroid Cancer: A Single-Institution Experience in Korea. Cancers (Basel). Kim MJ, Kim JK, Kim GJ, Kang SW, Lee J, Jeong JJ, Chung WY, Kim D, Nam KH.2022 Oct 8;14(19):4928.
Use of long non-coding RNAs for the molecular diagnosis of papillary thyroid cancer. Kim D, Yu J, Kim J, Hwang YA, Kim JK, Ku CR, Yoon JH, Kwak JY, Nam KH, Lee EJ. Front Oncol. 2022 Sep 5;12:924409. doi: 10.3389/fonc.2022.924409.
Vitamin D Receptor Expression and its Clinical Significance in Papillary Thyroid Cancer. Kim MJ, Kim D, Koo JS, Lee JH, Nam KH. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221089933.
Lactate Dehydrogenase A as a Potential New Biomarker for Thyroid Cancer. Ban EJ, Kim D, Kim JK, Kang SW, Lee J, Jeong JJ, Nam KH, Chung WY, Kim K. Endocrinol Metab (Seoul). 2021 Feb;36(1):96-105
Promotion of tumor progression and cancer stemness by MUC15 in thyroid cancer via the GPCR/ERK and integrin-FAK signaling pathways. Choi C, Thi Thao Tran N, Van Ngu T, Park SW, Song MS, Kim SH, Bae YU, Ayudthaya PDN, Munir J, Kim E, Baek MJ, Song S, Ryu S, Nam KH. Oncogenesis. 2018 Nov 12;7(11):85.
5. My publications related to developing new anti-adhesive agent
Efficacy and safety of temperature-sensitive acellular dermal matrix in prevention of postoperative
adhesion after thyroidectomy: A randomized, multicenter, double-blind, non-inferiority study. Kim JK, Lee CR, Kang SW, Jeong JJ, Nam KH, Cho SR, Jo S, Kim EY, Yun JS, Park HJ, Kim MS, Kim K, Lee S, Bae JS, Jun SY, Park J, Kim JS. PLoS One. 2022 Sep 19;17(9):e0273215.
Development of novel biocompatible thermosensitive anti-adhesive agents using human-derived acellular dermal matrix. Jeong JJ, Lee DW, Song SY, Park Y, Kim JH, Kim JI, Kim HG, Nam KT, Lee WJ, Nam KH, Lee JH. PLoS One. 2019 Feb 22;14(2):e0212583.
Complete List of Published Work in MyBibliography:
My ORCID : 0000-0002-6852-1190
ISOPES: 5 November 2025, Wednesday